Viewing Study NCT06390371



Ignite Creation Date: 2024-05-06 @ 8:28 PM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06390371
Status: RECRUITING
Last Update Posted: 2024-06-12
First Post: 2024-04-15

Brief Title: Implementing the Spotlight AQ Platform in Adolescent Young Adult 16-25 Years Old Type 1 Diabetics T1D
Sponsor: Childrens Mercy Hospital Kansas City
Organization: Childrens Mercy Hospital Kansas City

Study Overview

Official Title: Spotlight AQ Randomized Controlled Trial of the Spotlight AQ Survey Platform to Evaluate Its Efficacy and Applicability in a Clinic Setting
Status: RECRUITING
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to compare the Spotlight AQ survey platform to the standard of care SOC pre-clinic assessment in adolescents young adults 16-25 years old with Type 1 Diabetes T1D

The main questions it aims to answer are

Does using the Spotlight AQ survey in clinic decrease the A1c in the people who use it
Do patients and healthcare providers like using the spotlight AQ survey

Participants will use the Spotlight AQ survey before coming in to two standard of care T1D clinic visits Participants will fill out surveys describing how they feel about using the Spotlight AQ survey Some participants may be asked to do an interview to talk about how they feel about the Spotlight AQ survey
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None